Chemoinformaics analysis of 4,4-DIMETHYLTETRACYCLO[6.3.2.01,8.02,5]TRIDECAN-9-OL
Molecular Weight | 220.356 | nRot | 0 |
Heavy Atom Molecular Weight | 196.164 | nRig | 34 |
Exact Molecular Weight | 220.183 | nRing | 4 |
Solubility: LogS | -2.016 | nHRing | 0 |
Solubility: LogP | 1.632 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.855 |
nHD | 1 | BPOL | 24.077 |
QED | 0.063 |
Synth | 4.515 |
Natural Product Likeliness | 0.752 |
NR-PPAR-gamma | 0.541 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.215 |
Pgp-sub | 0 |
HIA | 0.997 |
CACO-2 | -7.085 |
MDCK | 0.00000931 |
BBB | 0.004 |
PPB | 0.835412 |
VDSS | 0.39 |
FU | 0.238084 |
CYP1A2-inh | 0.293 |
CYP1A2-sub | 0.008 |
CYP2c19-inh | 0.013 |
CYP2c19-sub | 0.016 |
CYP2c9-inh | 0.371 |
CYP2c9-sub | 0.018 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.071 |
CYP3a4-inh | 0.025 |
CYP3a4-sub | 0.004 |
CL | 13.877 |
T12 | 0.985 |
hERG | 0.077 |
Ames | 0.047 |
ROA | 0 |
SkinSen | 0.968 |
Carcinogencity | 0.007 |
EI | 0.934 |
Respiratory | 0.001 |
NR-Aromatase | 0.482 |
Antiviral | Yes |
Prediction | 0.864709 |